Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$165.3 - $226.0 $6,116 - $8,362
-37 Reduced 5.29%
662 $142,000
Q2 2023

Aug 15, 2023

SELL
$226.52 - $324.64 $5,209 - $7,466
-23 Reduced 3.19%
699 $226,000
Q1 2023

May 17, 2023

BUY
$229.06 - $278.01 $5,268 - $6,394
23 Added 3.29%
722 $169,000
Q4 2022

Feb 10, 2023

SELL
$164.02 - $259.76 $32,147 - $50,912
-196 Reduced 21.9%
699 $175,000
Q3 2022

Dec 05, 2022

BUY
$170.68 - $226.46 $4,949 - $6,567
29 Added 3.35%
895 $159,000
Q3 2021

Nov 12, 2021

SELL
$170.0 - $258.58 $510 - $775
-3 Reduced 0.35%
866 $202,000
Q1 2021

Apr 30, 2021

SELL
$182.45 - $249.25 $13,683 - $18,693
-75 Reduced 7.94%
869 $180,000
Q4 2020

Jan 25, 2021

SELL
$119.35 - $200.46 $13,844 - $23,253
-116 Reduced 10.94%
944 $178,000
Q3 2020

Nov 12, 2020

SELL
$87.5 - $130.91 $16,275 - $24,349
-186 Reduced 14.93%
1,060 $137,000
Q2 2020

Aug 13, 2020

BUY
$49.5 - $97.93 $61,677 - $122,020
1,246 New
1,246 $108,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $4.97B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.